Programmed cell death 1: Difference between revisions
Jump to navigation
Jump to search
| Line 24: | Line 24: | ||
*Pembrolizumab. | *Pembrolizumab. | ||
*Nivolumab. | *Nivolumab. | ||
*Atezolizumab. | |||
*Durvalumab. | |||
*Avelumab. | |||
Uncertain whether it binds PD-L1: | Uncertain whether it binds PD-L1: | ||